Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
30.07. | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 30.07.2024 | 730 | Xetra Newsboard | The following instruments on XETRA do have their first trading 30.07.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 30.07.2024
Aktien
1 US1712691039 Chugai Pharmaceutical... ► Artikel lesen | |
24.06. | Chugai Pharmaceutical-Aktie heute gut behauptet: Aktienwert steigt (31,305 €) | 374 | ARIVA.de | An der Börse notiert die Chugai Pharmaceutical-Aktie gegenwärtig etwas fester. Das Wertpapier notiert aktuell bei 31,31 Euro. Der Anteilsschein von Chugai Pharmaceutical verzeichnet derzeit einen Preisanstieg... ► Artikel lesen | |
12.06. | Helsinn Healthcare S.A.: Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland | 779 | GlobeNewswire (Europe) | Helsinn Group and Chugai Pharma Europe sign a partnership agreement renewal to commercialize AKYNZEO® in the UK and Ireland
Lugano, Switzerland - June 12, 2024 - Helsinn Group ("Helsinn"), a global... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
TRULIEVE CANNABIS | 11,300 | 0,00 % | Trulieve Has Spent $141M On Push For Florida Marijuana Amendment | ||
WEST PHARMACEUTICAL SERVICES | 291,10 | -0,38 % | West Pharmaceutical Services Aktie: Zukunftsplan mit Erfolg | West Pharmaceutical Services, Inc. hat mit seinen jüngsten Quartalszahlen die Erwartungen übertroffen und damit für Aufsehen an der Börse gesorgt. Der Aktienkurs des Medizintechnikunternehmens reagierte... ► Artikel lesen | |
SHIONOGI | 13,500 | +0,75 % | Shionogi's Xocova effective in preventing symptomatic COVID-19: study | ||
HERITAGE CANNABIS | 0,001 | 0,00 % | Heritage Cannabis Holdings Corp.: Heritage Cannabis Announces Completion of Sale and Delisting from the CSE and the OTCQX | TORONTO, Aug. 29, 2024 /CNW/ - Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") today announces, that, in connection with its creditor protection proceedings... ► Artikel lesen | |
KALA BIO | 6,405 | +2,89 % | KALA BIO: Vorstandsmitglied tritt zurück | ||
CHARLOTTES WEB | 0,106 | -5,36 % | Charlotte's Web Holdings Aktie: Umsatzrückgang belastet Aktienkurs | ||
BEXIMCO | 0,344 | 0,00 % | Beximco Pharma. - Notification of Preliminary Results and AGM | ||
LUYE PHARMA | 0,334 | -1,76 % | LUYE PHARMA (02186): OVERSEAS REGULATORY ANNOUNCEMENT | ||
MIRUM PHARMACEUTICALS | 36,200 | -3,21 % | Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Given Average Rating of "Buy" by Analysts | ||
GUARDION HEALTH SCIENCES | 2,740 | 0,00 % | Guardion Health Sciences, Inc.: Guardion Health Sciences Announces Filing of Certificate of Dissolution | HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) ("Guardion" or the "Company") today announced that it has filed a certificate of dissolution with the... ► Artikel lesen | |
PERCHERON THERAPEUTICS | 0,046 | -3,77 % | PERCHERON THERAPEUTICS LIMITED: Quarterly Activities Report and Appendix 4C | ||
AYURCANN | 0,020 | +5,41 % | Ayurcann Holdings Corp.: Ayurcann Reports Fiscal Year 2024 Record Sales Of $45,265,235 In Gross Revenue, Featuring Another 100% Year-over-year Increase | Toronto, Ontario, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: AYURF, FSE: 3ZQ0) ("Ayurcann" or the "Company"), a leading Canadian processing and manufacturing company... ► Artikel lesen | |
KALBE FARMA | 0,084 | -2,89 % | KLBF strengthens prescription drug business by inaugurating radioisotope factory: PT Kalbe Farma Tbk ... | ||
AVANT BRANDS | 0,600 | 0,00 % | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen | |
EVEREST MEDICINES | 3,680 | -1,08 % | Everest Medicines Limited: Everest Medicines Announces the Launch of VELSIPITY(R) in the Guangdong-Hong Kong-Macau Greater Bay Area | - Offering a New Option for Moderately to Severely Active Ulcerative Colitis PatientsHONG KONG, Oct 25, 2024 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical... ► Artikel lesen |